Join
Live feed
·
PRReleasevia Quantisnow
Alvotech logo

Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets

ByQuantisnow·Wall Street's wire, on your screen.
ALVO· Alvotech
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALVO (Alvotech) and more on Quantisnow.